MDM2 Expression in Aortic Smooth Muscle Cells in Rat Model of Hyperaldosteronism

王超,闫永吉,欧阳金芝,贺德华,史涛坪,居正华,张国玺,王保军,徐华,马鑫,李宏召,张旭
DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2009.05.031
2009-01-01
Abstract:Objective To study the effect of aldosterone on routine double minute2 (MDM2) gene expression in rat aortic smooth muscle cells in vivo. Methods Spragne-Dawley rats(n = 8 in each group) were randomly assigned to receive one of the following combinations via a mini-osmotic pump for 4 weeks: vehicle(60% propylene glycol + 10% ethanol + 30% ddH<.2> O, V/V, subcutaneously), aldosterone(1 μg/h, subcutaneously), or spironolaetone(100 mg/kg every day,gastric garage) plus the equal doses of aldosterone. Systolic blood pressure was monitored by the tail-eutI method weekly. All animals were sac-rificed 4 weeks later, then serum Na + , K+ ,aldosterone and PRA were measured. The M DM2 gene expres-sion in rat aortic smooth muscle cells was detected by RT-PCR, Western blot and immunohistoehemieal staining. Results(1)The hyperaldosteronism models were successfully established. In aldosterone-in-fused group systolic blood pressure was markedly elevated, the serum levels of K* and PRA were de-creased, and plasma aldostemne level was increased as compared with controls(P < 0. 01);(2)Aldoste-rune infusion could increase the MI)M2 gene expression in rat aorta as compared with controls(P < 0.01 ). All the above detrimental effects of aldosterone could be inhibited by spimnolaetone(P <0.01 ). Conclusion Aldosterone promotes the expression of MDM2 gene in aortic smooth muscle cells in vivo, which can be inhibited by spimnolaetone.
What problem does this paper attempt to address?